Cardiotoxicity: Elevations of Cardiac Troponin-I Quantified with the Erenna cTnl Immunoassay>

Application Articles

Cardiotoxicity: Elevations of Cardiac Troponin-I Quantified with the Erenna cTnl Immunoassay
9 Oct 2012

In this application note, cTnl measured by the Erenna® Immunoassay System, from Singulex, was more sensitive than histopathology and other clinical platforms currently available to identify acute cardiotoxicity. The potential of the Erenna cTnl assay for improving the safety profiles of candidate drugs is also demonstrated.